Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001698530-19-000086
Filing Date
2019-07-22
Accepted
2019-07-22 18:59:23
Documents
2
Period of Report
2019-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156383634753056.html 3  
1 FORM 3 wf-form3_156383634753056.xml 3 1693
2 EXHIBIT 24.1 CLELAND POA ex-24.htm EX-24 4049
  Complete submission text file 0001698530-19-000086.txt   7198
Mailing Address C/O VERSARTIS, INC. 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY CA 94065
Business Address
Cleland Jeffrey L (Reporting) CIK: 0001601948 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55764 | Film No.: 19966589

Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations